Proportional mouse model for aerosol infection by influenza

Aims The aim of this study was to demonstrate a prototype tool for measuring infectivity of an aerosolized human pathogen – influenza A/PR/8/34 (H1N1) virus – using a small‐animal model in the Controlled Aerosol Test System (CATS). Methods and Results Intranasal inoculation of nonadapted H1N1 virus...

Full description

Saved in:
Bibliographic Details
Published in:Journal of applied microbiology Vol. 113; no. 4; pp. 767 - 778
Main Authors: McDonald, R.S., Sambol, A.R., Heimbuch, B.K., Brown, T.L., Hinrichs, S.H., Wander, J.D.
Format: Journal Article
Language:English
Published: Oxford Blackwell Publishing Ltd 01-10-2012
Blackwell
Oxford University Press
John Wiley and Sons Inc
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Aims The aim of this study was to demonstrate a prototype tool for measuring infectivity of an aerosolized human pathogen – influenza A/PR/8/34 (H1N1) virus – using a small‐animal model in the Controlled Aerosol Test System (CATS). Methods and Results Intranasal inoculation of nonadapted H1N1 virus into C57BL, BALB/c and CD‐1 mice caused infection in all three species. Respiratory exposure of CD‐1 mice to the aerosolized virus at graduated doses was accomplished in a modified rodent exposure apparatus. Weight change was recorded for 7 days postexposure, and viral populations in lung tissue homogenates were measured post mortem by DNA amplification (qRT‐PCR), direct fluorescence and microscopic evaluation of cytopathic effect. Plots of weight change and of PCR cycle threshold vs delivered dose were linear to threshold doses of ~40 TCID50 and ~12 TCID50, respectively. Conclusions MID50 for inspired H1N1 aerosols in CD‐1 mice is between 12 and 40 TCID50; proportionality to dose of weight loss and viral populations makes the CD‐1 mouse a useful model for measuring infectivity by inhalation. Significance and Impact of the Study In the CATS, this mouse–virus model provides the first quantitative method to evaluate the ability of respiratory protective technologies to attenuate the infectivity of an inspired pathogenic aerosol.
Bibliography:The Air Force Research Laboratory (AFRL)
istex:2133E64584CDC2AB0BC29F834171F1B56923C187
ArticleID:JAM5402
Defence Threat Reduction Agency
ark:/67375/WNG-DC82Q8J6-0
Biological Advanced Research and Development Authority (BARDA)
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1364-5072
1365-2672
DOI:10.1111/j.1365-2672.2012.05402.x